ACP
Ashfield Capital Partners’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,019
| Closed | -$241K | – | 244 |
|
|
2019
Q1 | $241K | Sell |
1,019
-368
| -27% | -$87K | 0.03% | 232 |
|
|
2018
Q4 | $417K | Buy |
1,387
+368
| +36% | +$111K | 0.05% | 184 |
|
|
2018
Q3 | $360K | Hold |
1,019
| – | – | 0.04% | 210 |
|
|
2018
Q2 | $296K | Sell |
1,019
-864
| -46% | -$251K | 0.04% | 227 |
|
|
2018
Q1 | $516K | Sell |
1,883
-285
| -13% | -$78.1K | 0.07% | 192 |
|
|
2017
Q4 | $691K | Sell |
2,168
-124
| -5% | -$39.5K | 0.09% | 167 |
|
|
2017
Q3 | $718K | Sell |
2,292
-120
| -5% | -$37.6K | 0.1% | 163 |
|
|
2017
Q2 | $655K | Sell |
2,412
-9,252
| -79% | -$2.51M | 0.09% | 169 |
|
|
2017
Q1 | $3.19M | Sell |
11,664
-15,606
| -57% | -$4.27M | 0.44% | 71 |
|
|
2016
Q4 | $7.73M | Sell |
27,270
-9,854
| -27% | -$2.79M | 0.76% | 46 |
|
|
2016
Q3 | $11.6M | Sell |
37,124
-2,138
| -5% | -$669K | 0.96% | 37 |
|
|
2016
Q2 | $9.49M | Sell |
39,262
-4,439
| -10% | -$1.07M | 0.76% | 43 |
|
|
2016
Q1 | $11.4M | Buy |
43,701
+1,363
| +3% | +$355K | 0.82% | 43 |
|
|
2015
Q4 | $13M | Sell |
42,338
-39,097
| -48% | -$12M | 0.89% | 41 |
|
|
2015
Q3 | $23.8M | Sell |
81,435
-12,284
| -13% | -$3.58M | 1.53% | 19 |
|
|
2015
Q2 | $37.9M | Sell |
93,719
-2,308
| -2% | -$932K | 2.08% | 6 |
|
|
2015
Q1 | $40.5M | Sell |
96,027
-19,102
| -17% | -$8.07M | 2.16% | 7 |
|
|
2014
Q4 | $39.1M | Buy |
115,129
+19,980
| +21% | +$6.78M | 1.89% | 11 |
|
|
2014
Q3 | $31.5M | Buy |
95,149
+44,270
| +87% | +$14.6M | 1.53% | 21 |
|
|
2014
Q2 | $16M | Buy |
+50,879
| New | +$16M | 0.75% | 50 |
|